Pradaxa 75 mg hard capsules, BAY 3427080 clinical trials

(22081) Open-label, fixed sequence crossover study to determine the effects of a single dose of elinzanetant (BAY 3427080) on the pharmacokinetics of dabigatran etexilate in healthy participants

This study is looking at how a new drug, BAY 3427080, affects levels of an existing blood-thinning medicine called dabigatran (Pradaxa) in healthy people. Researchers want to see if taking them together changes how much dabigatran is in the body.